Physician Assistant, Medical · Raleigh, NC
NPI
1891356853
Since 2019
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2709 Blue Ridge Rd Ste 320
Raleigh, NC, 27607
Phone (919) 876-7692
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.4M
3,784 prescriptions
Company payments, 2025
$3,631
From 31 companies
Medicare prescription drug claims, 2024
In 2024, the drug Abigail W Terkeltoub prescribed most often to Medicare patients was Ozempic (Semaglutide), with 304 prescriptions and refills. In total Abigail W Terkeltoub wrote 3,784 Medicare prescriptions that cost $2.4M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ozempic Semaglutide | 304 | 538 | 73 | $517K |
| Levothyroxine Sodium Generic | 275 | 733 | 84 | $5,362 |
| Synthroid Levothyroxine Sodium | 256 | 550 | 57 | $23K |
| Jardiance Empagliflozin | 168 | 379 | 57 | $212K |
| Rosuvastatin Calcium Generic | 149 | 397 | 45 | $2,273 |
| Metformin Hcl Er Metformin Hcl | 148 | 406 | 48 | $2,117 |
| Mounjaro Tirzepatide | 139 | 203 | 30 | $210K |
| Farxiga Dapagliflozin Propanediol | 98 | 164 | 18 | $91K |
| Atorvastatin Calcium Generic | 94 | 233 | 25 | $655 |
| Tresiba Flextouch U-200 Insulin Degludec | 88 | 208 | 29 | $145K |
| Metformin Hcl Generic | 86 | 238 | 33 | $681 |
| Tresiba Flextouch U-100 Insulin Degludec | 75 | 163 | 30 | $70K |
| Glimepiride Generic | 70 | 181 | 20 | $819 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 67 | 151 | 27 | $7,512 |
| Trulicity Dulaglutide | 56 | 105 | 15 | $103K |
Brand drugs: 2,170 claims; generic drugs: 1,349 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Abigail W Terkeltoub $3,631 ($3,631 in general payments such as food, travel and fees) from 31 companies. The largest payer was Ascendis Pharma Endocrinology Inc with $342.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.